TABLE 5.
ADME and drug likeness properties of selected bioactive isolated compounds from methanol extract of C. gigantea.
Compound name | MW a | HB donors b | HB acceptors c | SASAd | QPlogPo/we | QPlogBBf | QPlogSg | %Human oral absorption h |
---|---|---|---|---|---|---|---|---|
Vitamin E acetate | 472.75 | 0 | 3.25 | 772.266 | 8.151 | −0.358 | −7.034 | 100 |
Methyl gamma-linolenate | 292.461 | 0 | 2 | 609.328 | 5.485 | −0.605 | −4.60 | 100 |
Clionasterol | 414.713 | 1 | 1.7 | 756.851 | 7.473 | −0.337 | −8.353 | 100 |
Juniper camphor | 222.37 | 1 | 0.75 | 450.587 | 3.96 | 0.391 | −3.965 | 100 |
Ethyl 4-fluoro-1-methyl-1H-imidazole-5-carboxylate | 172.159 | 0 | 3.5 | 390.235 | 1.207 | −0.098 | −1.605 | 92.876 |
Bicyclo[3.3.1]nonane-2,4-dione, 9,9-dimethoxy- | 212.245 | 0 | 5.5 | 407.383 | 0.545 | −0.235 | −0.732 | 86.661 |
Alpha-amyrin | 426.724 | 1 | 1.7 | 674.998 | 6.947 | 0.191 | −7.806 | 100 |
Moretenone | 424.709 | 0 | 2 | 692.442 | 7.036 | 0.163 | −8.129 | 100 |
6-Methoxy-2,5,8-trimethyl 2-(4,8,12trimethyltridecyl) 3,4-dihydrochromene | 430.713 | 0 | 1.5 | 753.331 | 6.351 | 0.986 | −12.387 | 100 |
Betulinaldehyde | 440.708 | 1 | 3.7 | 690.396 | 5.918 | −0.34 | −7.009 | 100 |
Bicyclo[4.3.0]nonane, 1 isopropenyl-4,5-dimethyl-5-phenylsulfonylmethyl | 346.527 | 0 | 4 | 588.762 | 4.457 | −0.013 | −4.629 | 100 |
Tert-Butyl(5-isopropyl-2-methylphenoxy)dimethylsilane | 264.482 | 0 | 0.85 | 550.079 | 4.574 | 0.746 | −7.589 | 100 |
Behenyl behenate | 649.178 | 0 | 3 | 1729.5 | 15.728 | −0.045 | −27.42 | 100 |
Ergost-5-en-3-ol, (3.beta.,24R)- | 400.687 | 1 | 1.7 | 745.016 | 7.225 | −0.283 | −8.295 | 100 |
Erucic acid | 338.573 | 1 | 2.75 | 861.367 | 6.08 | −0.755 | −10.855 | 100 |
Glyceryl palmitate | 330.507 | 2 | 5 | 886.624 | 4.614 | −1.036 | −10.395 | 100 |
Methyl heneicosanoate | 340.588 | 1 | 3 | 903.182 | 6.741 | 0.158 | −11.692 | 100 |
Methyl palmitate | 270.454 | 0 | 2 | 721.861 | 5.815 | −0.926 | −6.57 | 100 |
Ethyl linoleate | 308.503 | 0 | 3 | 670.733 | 4.826 | 0.25 | −7.357 | 100 |
1,3-Dihydroxypropan-2-yl (9E,12E,15E)-octadeca 9,12,15-trienoate | 352.513 | 2 | 4 | 812.017 | 4.485 | −0.584 | −9.404 | 100 |
Palmitic acid | 256.428 | 1 | 2 | 678.44 | 5.303 | −1.492 | −5.64 | 87.371 |
Stearic acid | 284.481 | 1 | 2.75 | 770.357 | 4.965 | −0.704 | −9.168 | 100 |
Glyceryl monostearate | 358.56 | 2 | 5 | 960.581 | 5.385 | −1.107 | −11.735 | 100 |
Olean-12-en-3-ol, acetate, (3.beta.)- | 454.735 | 0 | 2 | 725.863 | 7.292 | −0.223 | −8.762 | 100 |
Methyl pentadecanoate | 256.428 | 0 | 2 | 688.711 | 5.42 | −0.848 | −6.105 | 100 |
Phytol | 296.535 | 1 | 1.7 | 639.152 | 5.819 | −0.767 | −5.024 | 100 |
Tridecanedial | 212.331 | 0 | 4 | 573.453 | 2.492 | −1.633 | −3.036 | 88.392 |
Trilinolein | — | — | — | — | — | — | — | — |
Methyl n-undecanoate | 200.32 | 0 | 2 | 556.54 | 3.834 | −0.542 | −4.251 | 100 |
Vitamin E | 430.713 | 1 | 1.5 | 732.405 | 7.983 | −0.522 | −6.998 | 100 |
Nelfinavir | 567.785 | 4 | 9.95 | 922.327 | 4.344 | −0.966 | −5.652 | 79.965 |
Lopinavir | 628.81 | 9.833 | 3.083 | 822.525 | 4.933 | 0.195 | −7.416 | 96.153 |
Molecular weight (acceptable range: < 500).
Hydrogen bond donor (acceptable range: ≤5).
Hydrogen bond acceptor (acceptable range: ≤10).
Total Solvent Accessible Surface Area in using a probe with a 1.4 radius (acceptable range: 300–1,000).
Predicted octanol/water partition coefficient (acceptable range: − 2–6.5).
Predicted blood-brain partition co-efficient (acceptable range: −3–1.2).
Predicted aqueous solubility, S in mol/dm−3 (acceptable range: −6.5–0.5).
Predicted human oral absorption on 0–100% scale (<25% is poor and >80% is high).